Top Tech Startups in California, US in 2024

Globaltech Corporation operates as a telecom investment company. The Company offers services by providing access to the capital markets and technologies for the growth in telecom infrastructures. Globaltech serves clients worldwide. Leveraging our expertise and network to invest in companies that demonstrate exceptional business potential in exponential technologies

EliseAI is a machine learning technology company based in New York City. Our mission is to create conversational artificial intelligence that transforms industries crucial to sustaining our lives, starting with housing and healthcare. Our state-of-the-art AI Assistant automates customer conversations across multiple channels to elevate customer service and improve the bottom line. Email, text, webchat, phone; we've built artificial intelligence that can respond to leads and customers 24/7 with accurate and helpful information. As of 2023, we’ve partnered with the top 200 property managers in America to automate leasing and increase access to housing. Right now, we're in the process of expanding our offerings from the multifamily industry to encompass more industries, including healthcare. We're seeking candidates to join our fast-paced environment and tight-knit team committed to making a positive impact. Discover opportunities: eliseai.com/careers

The iRocket Community offers a distinctive blend of features designed to empower technology enthusiasts and entrepreneurs. At its core, the platform enables robust networking and collaboration, allowing members to forge valuable connections, share ideas, and collaborate on projects. This not only fosters a vibrant community but also promotes a sense of belonging and mutual support among diverse participants. A cornerstone of iRocket Community is its wealth of educational resources, including expert-led workshops, webinars, and mentorship programs. These resources are crafted to keep members at the forefront of industry trends and developments, enhancing their skills and competitive edge in the market. Furthermore, iRocket Community provides unique platforms like virtual incubator programs and pitch events, offering members opportunities to gain visibility for their ventures and connect with potential investors. This feature is instrumental in driving the growth and success of emerging startups within the community. The integration of these features results in a comprehensive ecosystem that supports professional development, innovation, and collaboration. Members benefit from increased access to learning opportunities, a stronger network of industry connections, and a supportive environment that champions their success. Through its targeted offerings, the iRocket Community stands out as a nurturing ground for the next generation of tech leaders and entrepreneurs.

Lumo is a smart irrigation system for vineyards that helps growers save water, reduce costs and improve grape quality. With Lumo, growers gain unprecedented visibility and control, enabling them to irrigate more precisely and efficiently. Since Lumo is cloud-managed, it can be controlled and monitored from anywhere, reducing the number of required site visits, time spent on-site, and thereby reducing labor costs. To learn more about Lumo, visit Lumo.Ag

IonPath is a Stanford University spin-out with a vision to transform clinical pathology and tumor imaging, a $10B+ market, with the company's novel, highly multi-parametric imaging technology, Multiplexed Ion Beam Imaging (MIBI). IonPath's MIBI is a step-change improvement over the current leading tumor imaging method, immunohistochemistry (IHC). MIBI enables researchers, pathologists, and clinicians to quantitatively analyze and visually display the complex interactions among cancer tumor cells, proteins, antibodies, T-cells, and other relevant features on cells' surfaces and interiors. Understanding these biological players and their interactions should substantially improve cancer research and drug discovery, produce novel diagnostics, and transform the study of disease mechanisms such as cancer ("pathology"). IonPath will develop and commercialize services, instruments, reagents, and ultimately diagnostic tests based on MIBI technology.